Mantle Cell Lymphoma Treatment in Delhi, India

Mantle cell lymphoma (MCL) is a rare type of blood cancer that starts in the lymphatic system, the part of the body that helps fight infections. It develops in special white blood cells called B-cells, which are found in a section of the lymph nodes known as the mantle zone.

In MCL, these B-cells start growing in an uncontrolled way. Because of this rapid growth, the lymphoma often spreads quickly to different parts of the body. It may involve lymph nodes, bone marrow, the spleen, and sometimes the digestive tract.

Although considered rare, mantle cell lymphoma is known for being more aggressive than many other types of non-Hodgkin lymphoma. This means it can progress swiftly and usually requires timely, well-planned medical care.

Even though MCL is a complex condition, advances in modern diagnostics and personalised treatment approaches have greatly improved how it is managed. Early understanding and specialist evaluation play an important role in helping patients receive the right care and support from the start.

Mantle cell lymphoma (MCL) is a rare type of blood cancer that starts in the lymphatic system, the part of the body that helps fight infections. It develops in special white blood cells called B-cells, which are found in a section of the lymph nodes known as the mantle zone.

In MCL, these B-cells start growing in an uncontrolled way. Because of this rapid growth, the lymphoma often spreads quickly to different parts of the body. It may involve lymph nodes, bone marrow, the spleen, and sometimes the digestive tract.

Although considered rare, mantle cell lymphoma is known for being more aggressive than many other types of non-Hodgkin lymphoma. This means it can progress swiftly and usually requires timely, well-planned medical care.

Even though MCL is a complex condition, advances in modern diagnostics and personalised treatment approaches have greatly improved how it is managed. Early understanding and specialist evaluation play an important role in helping patients receive the right care and support from the start.

Staging mantle cell lymphoma helps doctors understand how far the cancer has spread and which parts of the body are affected. This information is important for choosing the most suitable treatment plan. Like many lymphomas, mantle cell lymphoma is staged using the Ann Arbor system, which includes four stages.

Stage I

The lymphoma is found in one group of lymph nodes or in a single lymphatic area, such as the neck, armpit, or groin. It may also involve one nearby organ, but this is less common.

Stage II

The lymphoma is present in two or more groups of lymph nodes on the same side of the diaphragm (either all above or all below it). It may also extend to a nearby organ but does not spread to distant areas of the body.

Stage III

The lymphoma has spread to lymph node regions on both sides of the diaphragm. The spleen may also be involved at this stage.

Stage IV

The lymphoma has spread widely beyond the lymph nodes, commonly affecting the bone marrow, liver, digestive tract, or other organs. This is the most advanced stage, but treatment can still be effective depending on how the disease behaves.

The exact cause of mantle cell lymphoma (MCL) is not fully understood, but doctors know that it begins when certain white blood cells, called B-cells, develop changes in their DNA. These changes affect how the cells grow, divide, and survive, eventually leading to cancer.

One of the most important findings in MCL is a genetic alteration known as the t(11;14) translocation. This happens when pieces of chromosomes 11 and 14 swap places. As a result, a gene that controls cell growth becomes overactive, allowing B-cells to multiply much more than they should.

These faulty cells can then build up in the lymph nodes, bone marrow, and other parts of the body, causing the lymphoma to spread.

Although doctors understand this genetic process, they do not yet know why it happens in some people and not in others. Factors such as environmental exposures, previous infections, or family history may play a role, but none of these directly cause the disease on their own.

Several factors may increase the likelihood of developing mantle cell lymphoma. Some of the most common risk factors include:

• Age: MCL is more commonly diagnosed in adults, particularly those over the age of 60. It is rare in children and young adults.
• Gender: MCL is more common in men than in women. Men are generally at a higher risk for developing this condition.
• Family History: A family history of lymphoma or other cancers can increase the risk of developing MCL. Although most cases occur in individuals with no family history, genetics may still play a role.
• Weakened Immune System: People with weakened immune systems, such as those with HIV/AIDS or those who have received organ transplants and are on immunosuppressive drugs, may have an increased risk of lymphoma.
• Previous Infections: Certain viral infections, such as Epstein-Barr virus (EBV), have been linked to an increased risk of developing various lymphomas, including MCL.

The symptoms of mantle cell lymphoma can vary depending on the stage of the disease and which parts of the body are affected. Common symptoms include:

• Swollen Lymph Nodes: One of the most common signs is painless swelling of the lymph nodes, often in the neck, armpits, or groin. These swollen nodes may not be painful but can become tender over time.
• Fatigue: Feeling unusually tired or weak, even with adequate rest, is a frequent symptom. This fatigue may interfere with daily activities.
• Unexplained Weight Loss: Significant and unexplained weight loss without changes in diet or exercise habits may be an early sign of lymphoma.
• Night Sweats: Sweating excessively during sleep, to the point where the bedclothes are soaked, can be a common symptom of MCL.
• Fever: A low-grade fever, without an apparent cause, is often experienced by those with mantle cell lymphoma.
• Abdominal Discomfort: If the lymphoma affects the spleen or gastrointestinal tract, individuals may experience abdominal pain, bloating, or a feeling of fullness.
• Shortness of Breath: If MCL spreads to the chest or lungs, shortness of breath may occur, particularly when exerting oneself.

It's important to note that many of these symptoms can also be caused by conditions other than MCL, so it’s essential to see a healthcare provider for a proper diagnosis.

Diagnosing mantle cell lymphoma typically involves a combination of physical exams, medical history review, and several diagnostic tests. The process may include:

• Physical Exam: A healthcare provider will check for swollen lymph nodes, signs of infection, and any other physical abnormalities.
• Blood Tests: Blood tests help assess overall health, check for signs of anemia or infection, and can sometimes reveal abnormal levels of certain blood cells. Though blood tests alone can't confirm MCL, they can help support the diagnosis.
• Biopsy: The most definitive way to diagnose mantle cell lymphoma is through a biopsy. A sample of the affected lymph node or tissue is removed and examined under a microscope. The pathologist will look for the characteristic cancerous B-cells of MCL.
• Immunohistochemistry: This technique is used to identify specific proteins on the surface of the lymphoma cells. It helps differentiate mantle cell lymphoma from other types of lymphoma.
• Genetic Testing: Special tests can identify genetic mutations associated with MCL, such as the t(11;14) translocation. These tests help confirm the diagnosis and provide additional information on the type of lymphoma.
• Imaging Tests: CT scans, PET scans, or MRI scans may be used to detect the spread of the lymphoma to other parts of the body, such as the spleen, liver, or bones.
• Bone Marrow Biopsy: Since MCL often affects the bone marrow, a biopsy of the bone marrow may be done to determine whether the lymphoma has spread there.

Once these tests are complete, the healthcare team can stage the lymphoma and determine the best course of treatment.

The treatment for mantle cell lymphoma often depends on the stage of the disease, the patient’s overall health, and how aggressively the lymphoma is progressing. Treatment options typically include:

Chemotherapy

Chemotherapy is one of the most common treatments for MCL. It uses drugs to kill cancer cells or stop their growth. Chemotherapy can be given orally or through an intravenous (IV) infusion. It may be used alone or combined with other treatments.

Immunotherapy

Immunotherapy helps the immune system recognise and attack cancer cells. Monoclonal antibodies, like rituximab, are often used in combination with chemotherapy to target and destroy lymphoma cells more effectively.

Stem Cell Transplant

In cases where chemotherapy is not effective or the lymphoma recurs, a stem cell transplant (also known as a bone marrow transplant) may be considered. This procedure involves replacing the damaged bone marrow with healthy stem cells, either from the patient (autologous transplant) or a donor (allogeneic transplant).

Targeted Therapy

This treatment focuses on specific molecules or genes that allow cancer cells to grow. Targeted therapies, like Bruton's tyrosine kinase (BTK) inhibitors, are used to block the signals that promote the growth of MCL cells.

Radiation Therapy

Radiation therapy uses high-energy radiation to kill or shrink cancer cells. It is often used to treat localized tumours or to relieve symptoms caused by large tumour masses.

Watch and Wait

In some cases, particularly in early-stage or less aggressive forms of MCL, doctors may recommend a "watch and wait" approach. This means monitoring the lymphoma closely without immediate treatment unless the disease starts to progress.

Treatment is usually tailored to each patient, and a combination of therapies may be used to manage the disease effectively.

Mantle cell lymphoma can lead to several complications, particularly if it is not treated or managed properly. Some of the potential complications include:

• Infection: Due to the weakening of the immune system caused by both the lymphoma and its treatments (especially chemotherapy), patients with MCL are at an increased risk of infections. These can range from mild to severe, including respiratory infections and opportunistic infections.
• Bone Marrow Suppression: Chemotherapy and radiation therapy can lead to bone marrow suppression, which means the body produces fewer healthy blood cells. This can result in anemia (low red blood cell count), increased risk of bleeding (low platelet count), and a weakened immune system (low white blood cell count).
• Organ Damage: Lymphoma can spread to organs such as the spleen, liver, and kidneys, leading to organ dysfunction. Some treatments, like chemotherapy and radiation, can also cause damage to these organs over time.
• Relapse or Refractory Disease: MCL is an aggressive lymphoma, and in some cases, it may not respond to initial treatments or may return after treatment (relapse). When the lymphoma does not respond to treatment (refractory disease), it becomes more difficult to manage.
• Gastrointestinal Complications: MCL can sometimes involve the gastrointestinal tract, leading to issues like bowel obstructions, ulcers, or other digestive problems, which may require additional treatment or surgical interventions.
• Lymphoma-Related Lymphadenopathy: As the lymphoma progresses, swollen lymph nodes can lead to pain or pressure in various areas of the body, which may result in difficulty breathing, swallowing, or other discomforts, depending on where the affected lymph nodes are located.

Managing these complications often involves close monitoring and treatment adjustments to ensure that the patient’s overall health is supported during and after the treatment of MCL.

Currently, there is no known way to completely prevent mantle cell lymphoma, as the exact cause of the disease is not fully understood. However, there are some general steps that may help reduce the risk or support overall health:

• Leading a Healthy Lifestyle: Eating a balanced diet, exercising regularly, and maintaining a healthy weight can help keep the immune system strong. This may not directly prevent MCL, but overall health can play a role in reducing the risk of various types of cancer, including lymphomas.
• Avoiding Known Risk Factors: If possible, reducing exposure to known environmental risk factors, such as certain chemicals, radiation, and infections like Epstein-Barr virus (EBV), may help lower the risk.
• Managing Immune System Health: People with weakened immune systems, whether from conditions like HIV or immunosuppressive drugs, may be at higher risk for lymphoma. Maintaining good health and following medical advice for managing these conditions could help reduce the likelihood of developing MCL.
• Undergoing Regular Health Check-ups: For individuals who have a family history of lymphoma or other cancers, regular medical check-ups may allow for early detection of any signs of lymphoma, potentially leading to earlier treatment and better outcomes.

While there's no guaranteed way to prevent mantle cell lymphoma, taking steps to stay healthy and following medical advice can help reduce overall risk and lead to better management if the disease occurs.

How common is mantle cell lymphoma compared to other lymphomas?

Mantle cell lymphoma is considered uncommon, accounting for only a small percentage of all non-Hodgkin lymphoma cases. Its rarity is one of the reasons it requires evaluation by specialists experienced in treating complex lymphomas.

Can mantle cell lymphoma be detected through routine health screenings?

Routine screenings do not typically detect MCL unless blood tests or imaging incidentally show abnormalities. Most diagnoses occur only after symptoms appear or a scan is performed for another reason.

Does mantle cell lymphoma always spread outside the lymph nodes?

Not always, but it has a higher likelihood of spreading beyond lymph nodes compared to some other lymphomas. Common areas include the spleen, gastrointestinal tract, and bone marrow.

Is mantle cell lymphoma hereditary?

Most cases are not inherited. While a family history of blood cancers can slightly increase the risk, mantle cell lymphoma itself is not considered a genetic disease that passes directly from one generation to the next.

Can stress or lifestyle habits trigger mantle cell lymphoma?

There is no evidence that stress, diet, or routine lifestyle habits directly cause MCL. However, maintaining overall health may support the immune system during and after treatment.

What does it mean if mantle cell lymphoma is described as “indolent” or “aggressive”?

Some forms of MCL grow more slowly (“indolent”), while others progress rapidly. The doctor determines the behaviour of the lymphoma using biopsy results, genetic findings, and how the disease appears on imaging.

How long does treatment for mantle cell lymphoma typically last?

Treatment duration varies widely, depending on the stage of the disease and the therapies used. Chemotherapy may last several months, while targeted therapies or immunotherapies may continue for longer periods.

Can someone with mantle cell lymphoma travel during treatment?

Many patients can travel, but it depends on their treatment schedule, immune status, and overall health. Doctors often advise avoiding crowded places or high-risk areas when immunity is low.

Will I need lifelong follow-up after treatment for mantle cell lymphoma?

Yes. Because MCL can return even after successful treatment, long-term follow-up is essential. Regular appointments help detect recurrence early and monitor overall health.

Can mantle cell lymphoma affect mental and emotional well-being?

Yes, many patients experience stress, anxiety, or emotional fatigue. Support groups, counselling, and open communication with the care team can help patients and families cope better.

Is it possible to work while undergoing treatment for mantle cell lymphoma?

Some patients continue working, depending on the intensity of treatment and how they feel. Others may need reduced hours or temporary leave. Doctors can help guide what is safe and manageable.

Do all patients with mantle cell lymphoma require hospitalisation?

Not always. While some treatments are given in outpatient settings, others like stem cell transplants may require hospital stays. The need varies based on the treatment plan.

Can vaccinations be taken during treatment for mantle cell lymphoma?

Some vaccines are safe, while others are not recommended during periods of low immunity. Doctors usually advise on the best timing for vaccinations like flu or pneumonia shots.

Reviewed by Dr. Rayaz Ahmed, Principal Director - Haematology and Bone Marrow Transplant, Cancer Care / Oncology, Hematology Oncology, on 27 March 2026.